Literature DB >> 12183661

Molecular and pharmacological characterization of GABA(A) receptor alpha1 subunit knockout mice.

J E Kralic1, E R Korpi, T K O'Buckley, G E Homanics, A L Morrow.   

Abstract

GABA(A) receptors mediate fast inhibitory neurotransmission in the central nervous system (CNS), and approximately half of these receptors contain alpha1 subunits. GABA(A) receptor alpha1 subunits are important for receptor assembly and specific pharmacological responses to benzodiazepines. Plasticity in GABA(A) receptor alpha1 subunit expression is associated with changes in CNS excitability observed during normal brain development, in animal models of epilepsy, and upon withdrawal from alcohol and benzodiazepines. To examine the role of alpha1 subunit-containing GABA(A) receptors in vivo, we characterized receptor subunit expression and pharmacological properties in cerebral cortex of knockout mice with a targeted deletion of the alpha1 subunit. The mice are viable but exhibit an intention tremor. Western blot analysis confirms the complete loss of alpha1 subunit peptide expression. Stable adaptations in the expression of several GABA(A) receptor subunits are observed in the fifth to seventh generations, including decreased expression of beta2/3 and gamma2 subunits and increased expression of alpha2 and alpha3 subunits. There was no change in alpha4, alpha5, or delta subunit peptide levels in cerebral cortex. Knockout mice exhibit loss of over half of GABA(A) receptors measured by [(3)H]muscimol, [(3)H]2-(3-carboxyl)-3-amino-6-(4-methoxyphenyl)-pyridazinium bromide ([(3)H]SR-95531), and t-butylbicyclophosphoro[(35)S]thionate ([(35)S]TBPS) binding. [(3)H]Ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate ([(3)H]Ro15-4513) binding is reduced by variable amounts in different regions across brain. GABA(A) receptor alpha1(-/-) mice lose all high-affinity [(3)H]zolpidem binding and about half of [(3)H]flunitrazepam binding in the cerebral cortex. The potency and maximal efficacy of muscimol-stimulated (36)Cl(-) uptake in cerebral cortical synaptoneurosomes are reduced in alpha1(-/-) mice. Furthermore, knockout mice exhibit increased bicuculline-induced seizure susceptibility compared with wild-type mice. These data emphasize the significance of alpha1 subunit expression and its involvement in the regulation of CNS excitability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183661     DOI: 10.1124/jpet.102.036665

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  68 in total

Review 1.  Developmental aspects of spinal locomotor function: insights from using the in vitro mouse spinal cord preparation.

Authors:  Patrick J Whelan
Journal:  J Physiol       Date:  2003-10-03       Impact factor: 5.182

2.  Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task.

Authors:  Karina A Zanin; Camilla L Patti; Leandro Sanday; Luciano Fernandes-Santos; Larissa C Oliveira; Dalva Poyares; Sergio Tufik; Roberto Frussa-Filho
Journal:  Psychopharmacology (Berl)       Date:  2012-06-23       Impact factor: 4.530

3.  Amygdala-specific reduction of alpha1-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in mice.

Authors:  Scott A Heldt; Kerry J Ressler
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 4.  Diverse mechanisms of antiepileptic drugs in the development pipeline.

Authors:  Michael A Rogawski
Journal:  Epilepsy Res       Date:  2006-04-18       Impact factor: 3.045

Review 5.  Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey.

Authors:  Caroline Victorri-Vigneau; Eric Dailly; Gwenaëlle Veyrac; Pascale Jolliet
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

6.  Transcriptional signatures of cellular plasticity in mice lacking the alpha1 subunit of GABAA receptors.

Authors:  Igor Ponomarev; Rajani Maiya; Mark T Harnett; Gwen L Schafer; Andrey E Ryabinin; Yuri A Blednov; Hitoshi Morikawa; Stephen L Boehm; Gregg E Homanics; Ari E Berman; Ari Berman; Kerrie H Lodowski; Susan E Bergeson; R Adron Harris
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

Review 7.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 8.  GABAA receptor polymorphisms in alcohol use disorder in the GWAS era.

Authors:  Mairi Koulentaki; Elias Kouroumalis
Journal:  Psychopharmacology (Berl)       Date:  2018-05-02       Impact factor: 4.530

9.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

10.  Genetic variability in glutamic acid decarboxylase genes: associations with post-traumatic seizures after severe TBI.

Authors:  Shaun D Darrah; Megan A Miller; Dianxu Ren; Nichole Z Hoh; Joelle M Scanlon; Yvette P Conley; Amy K Wagner
Journal:  Epilepsy Res       Date:  2012-07-26       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.